On Oct 09, major Wall Street analysts update their ratings for $Accolade (ACCD.US)$, with price targets ranging from $5 to $9.
Morgan Stanley analyst Craig Hettenbach maintains with a hold rating, and maintains the target price at $6.
BofA Securities analyst Allen Lutz maintains with a buy rating, and adjusts the target price from $7 to $5.75.
Barclays analyst Stephanie Davis maintains with a hold rating, and maintains the target price at $5.
Needham analyst Ryan MacDonald maintains with a buy rating, and maintains the target price at $8.
BTIG analyst David Larsen maintains with a hold rating.
Furthermore, according to the comprehensive report, the opinions of $Accolade (ACCD.US)$'s main analysts recently are as follows:
The second quarter results for Accolade reiterated existing themes within the company, such as enhanced profitability in conjunction with moderated revenue growth. Revised forecasts for FY25 revenue and adjusted EBITDA have been issued post-report, with reductions reflecting diminished growth in PlushCare and across the broader business model, subsequently influencing EBITDA projections.
Post the fiscal Q2 report, there has been a rally in shares due to a 'solid print,' with the company maintaining its fiscal 2025 guidance, optimistic commentary about the selling season, and significant visibility into a 'steeper-than-usual' Q4 ramp. There appears to be a challenging near-term environment for securing new employer wins; however, the shift towards a 'honed focus on profitable growth' is seen in a positive light.
Here are the latest investment ratings and price targets for $Accolade (ACCD.US)$ from 8 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美东时间10月9日，多家华尔街大行更新了$Accolade (ACCD.US)$的评级，目标价介于5美元至9美元。
摩根士丹利分析师Craig Hettenbach维持持有评级，维持目标价6美元。
美银证券分析师Allen Lutz维持买入评级，并将目标价从7美元下调至5.75美元。
巴克莱银行分析师Stephanie Davis维持持有评级，维持目标价5美元。
Needham分析师Ryan MacDonald维持买入评级，维持目标价8美元。
BTIG分析师David Larsen维持持有评级。
此外，综合报道，$Accolade (ACCD.US)$近期主要分析师观点如下：
Accolade第二季度业绩重申公司内部现有主题，如增强盈利能力与适度的营业收入增长。FY25营业收入和调整后的EBITDA的修订预测已经在报告后发布，调整反映了PlushCare和更广泛业务模式增长减弱，进而影响了EBITDA预测。
发布财政Q2报告后，股价出现回升，因为有一份'可喜的报告'，公司维持了其2025年财年指导，对销售季节表示乐观，而对'比平时更陡'的第四季度提供了明显的预期。似乎在近期面临着挑战的环境以确保赢得新雇主；然而，向着'专注于盈利增长'的转变被正面看待。
以下为今日8位分析师对$Accolade (ACCD.US)$的最新投资评级及目标价：
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
